Sign up to save your podcasts
Or
Share When Half Your Industry Thinks You're Dead Wrong | EP 115
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
When Half Your Industry Thinks You're Dead Wrong | EP 115
Mental health assessments rely on what people say they feel.
But what if words aren’t the most reliable signal?
In this episode of Scaling Without Breaking, host Roland Siebelink sits down with Bechara Saab, Co-Founder & CEO of Mobio Interactive, who is building technology that uses biomarkers from a simple selfie to assess mental well-being.
No long surveys.
No biased self-reporting.
No guesswork.
Instead, the conversation explores objective emotional measurement — using science and AI to uncover signals that traditional methods often miss.
Because the real challenge in mental health isn’t just access.
It’s accuracy.
In this episode, Roland and Bechara unpack what it takes to build and scale mental health technology and digital therapeutics with global potential.
Key Discussion Points
00:06 – From neuroscientist to building objective psychiatry
01:23 – Can a selfie measure emotions better than self-reporting?
02:41 – Why objective biomarkers outperform subjective data
03:39 – How Mobio’s platform delivers personalized therapy
05:26 – “Exercise for the brain” and expanding use cases
06:34 – Self-guided vs. provider-supported mental health care
07:22 – Business model across different healthcare systems
08:37 – Market expansion strategy: US, Canada, Singapore, India
09:17 – Why the founder is still the best dealmaker
09:44 – Rethinking sales: supporting founder-led sales instead of hiring more closers
10:46 – Scaling globally: serving both large institutions and individual practitioners
11:49 – Universal biomarkers vs. culturally localized therapy
13:16 – Childhood, freedom, and shaping leadership style
14:49 – What leadership actually requires beyond decision-making
16:12 – Leading with empathy (and “not nice” traits used for good)
17:07 – Advice for founders without a business background
18:52 – Choosing investors and protecting company culture
20:09 – Making the platform accessible to everyone
For founders building in AI, healthtech, or global platforms, this episode offers a new perspective on scaling innovation responsibly.
Mobio is also offering listeners access to a limited release of its latest platform.
Sign up here:
https://forms.gle/TRFjwKpwryThfJjSA
👍 Like if this changed how you think about mental health tech
🔔 Subscribe for more honest conversations about growth
💬 Comment with your biggest takeaway
🔗 Share this with someone building in AI or healthtech
#ScalingWithoutBreaking #MentalHealthTechnology #DigitalTherapeutics #ObjectiveEmotionalMeasurement #FounderLedSales #ScientistToCEO #HealthTech #StartupLeadership
View all episodes
By Roland SiebelinkMental health assessments rely on what people say they feel.
But what if words aren’t the most reliable signal?
In this episode of Scaling Without Breaking, host Roland Siebelink sits down with Bechara Saab, Co-Founder & CEO of Mobio Interactive, who is building technology that uses biomarkers from a simple selfie to assess mental well-being.
No long surveys.
No biased self-reporting.
No guesswork.
Instead, the conversation explores objective emotional measurement — using science and AI to uncover signals that traditional methods often miss.
Because the real challenge in mental health isn’t just access.
It’s accuracy.
In this episode, Roland and Bechara unpack what it takes to build and scale mental health technology and digital therapeutics with global potential.
Key Discussion Points
00:06 – From neuroscientist to building objective psychiatry
01:23 – Can a selfie measure emotions better than self-reporting?
02:41 – Why objective biomarkers outperform subjective data
03:39 – How Mobio’s platform delivers personalized therapy
05:26 – “Exercise for the brain” and expanding use cases
06:34 – Self-guided vs. provider-supported mental health care
07:22 – Business model across different healthcare systems
08:37 – Market expansion strategy: US, Canada, Singapore, India
09:17 – Why the founder is still the best dealmaker
09:44 – Rethinking sales: supporting founder-led sales instead of hiring more closers
10:46 – Scaling globally: serving both large institutions and individual practitioners
11:49 – Universal biomarkers vs. culturally localized therapy
13:16 – Childhood, freedom, and shaping leadership style
14:49 – What leadership actually requires beyond decision-making
16:12 – Leading with empathy (and “not nice” traits used for good)
17:07 – Advice for founders without a business background
18:52 – Choosing investors and protecting company culture
20:09 – Making the platform accessible to everyone
For founders building in AI, healthtech, or global platforms, this episode offers a new perspective on scaling innovation responsibly.
Mobio is also offering listeners access to a limited release of its latest platform.
Sign up here:
https://forms.gle/TRFjwKpwryThfJjSA
👍 Like if this changed how you think about mental health tech
🔔 Subscribe for more honest conversations about growth
💬 Comment with your biggest takeaway
🔗 Share this with someone building in AI or healthtech
#ScalingWithoutBreaking #MentalHealthTechnology #DigitalTherapeutics #ObjectiveEmotionalMeasurement #FounderLedSales #ScientistToCEO #HealthTech #StartupLeadership